QQ客服 官方微博 反馈留言

	TYPE IV COLLAGEN AS NOVEL NONINVASIVE BIOMARKER TO PREDICT FAILURE TO CONTROL BLEEDING AND EARLY REBLEEDING IN PATIENTS WITH CIRRHOSIS: A PROSPECTIVE, MULTICENTER STUDY
	Shao, Ruoyang; Zeng, Xiangbo; Liu, Chuan; Zhang, Chunqing; Wang, Yu; Qi, Ruizhao; Lin, Xinlong; Zhang, Yue; Wang, Jitao; Liu, Dengxi 更多
	2019
会议名称	Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
会议日期	NOV 08-12, 2019
卷号	70
页码	160A-160A
收录类别	CPCI-S ; SCIE
会议录	HEPATOLOGY
URL标识	查看原文
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/6024937
专题	山东大学
作者单位	1.Lanzhou Univ, Hosp 1, CHESS Ctr, Lanzhou, Peoples R China. 2.[Shao, Ruoyang
推荐引用方式 GB/T 7714	Shao, Ruoyang,Zeng, Xiangbo,Liu, Chuan,et al. TYPE IV COLLAGEN AS NOVEL NONINVASIVE BIOMARKER TO PREDICT FAILURE TO CONTROL BLEEDING AND EARLY REBLEEDING IN PATIENTS WITH CIRRHOSIS: A PROSPECTIVE, MULTICENTER STUDY[C]. 见:Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting. NOV 08-12, 2019.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。